Literature DB >> 14638786

A humoral immune response confers protection against Haemophilus ducreyi infection.

Leah E Cole1, Kristen L Toffer, Robert A Fulcher, Lani R San Mateo, Paul E Orndorff, Thomas H Kawula.   

Abstract

Haemophilus ducreyi is the etiologic agent of the sexually transmitted genital ulcer disease chancroid. Neither naturally occurring chancroid nor experimental infection with H. ducreyi results in protective immunity. Likewise, a single inoculation of H. ducreyi does not protect pigs against subsequent infection. Accordingly, we used the swine model of chancroid infection to examine the impact of multiple inoculations on a host's immune response. After three successive inoculations with H. ducreyi, pigs developed a modestly protective immune response evidenced by the decreased recovery of viable bacteria from lesions. All lesions biopsied 2 days after the first and second inoculations contained viable H. ducreyi cells, yet only 55% of the lesions biopsied 2 days after the third inoculation did. Nearly 90% of the lesions biopsied 7 days after the first inoculation contained viable H. ducreyi cells, but this percentage dropped to only 16% after the third inoculation. Between the first and third inoculations, the average recovery of CFU from lesions decreased approximately 100-fold. The reduced recovery of bacteria corresponded directly with a fivefold increase in H. ducreyi-specific antibody titers and the emergence of bactericidal activity. These immune sera were protective when administered to naïve pigs prior to challenge with H. ducreyi. These data suggest that pigs mount an effective humoral immune response to H. ducreyi after multiple exposures to the organism.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14638786      PMCID: PMC308944          DOI: 10.1128/IAI.71.12.6971-6977.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  52 in total

1.  Haemophilus ducreyi associates with phagocytes, collagen, and fibrin and remains extracellular throughout infection of human volunteers.

Authors:  M E Bauer; M P Goheen; C A Townsend; S M Spinola
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

2.  Relative risks and population attributable fraction of incident HIV associated with symptoms of sexually transmitted diseases and treatable symptomatic sexually transmitted diseases in Rakai District, Uganda. Rakai Project Team.

Authors:  R H Gray; M J Wawer; N K Sewankambo; D Serwadda; C Li; L H Moulton; T Lutalo; F Wabwire-Mangen; M P Meehan; S Ahmed; L A Paxton; N Kiwanuka; F Nalugoda; E L Korenromp; T C Quinn
Journal:  AIDS       Date:  1999-10-22       Impact factor: 4.177

3.  Characterization of Haemophilus ducreyi-specific T-cell lines from lesions of experimentally infected human subjects.

Authors:  V Gelfanova; T L Humphreys; S M Spinola
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

4.  A superoxide dismutase C mutant of Haemophilus ducreyi is virulent in human volunteers.

Authors:  Cliffton T H Bong; Kate R Fortney; Barry P Katz; Antoinette F Hood; Lani R San Mateo; Thomas H Kawula; Stanley M Spinola
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

5.  Expression of cytolethal distending toxin and hemolysin is not required for pustule formation by Haemophilus ducreyi in human volunteers.

Authors:  R S Young; K R Fortney; V Gelfanova; C L Phillips; B P Katz; A F Hood; J L Latimer; R S Munson; E J Hansen; S M Spinola
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

6.  DsrA-deficient mutant of Haemophilus ducreyi is impaired in its ability to infect human volunteers.

Authors:  C T Bong; R E Throm; K R Fortney; B P Katz; A F Hood; C Elkins; S M Spinola
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

7.  Expression of peptidoglycan-associated lipoprotein is required for virulence in the human model of Haemophilus ducreyi infection.

Authors:  K R Fortney; R S Young; M E Bauer; B P Katz; A F Hood; R S Munson; S M Spinola
Journal:  Infect Immun       Date:  2000-11       Impact factor: 3.441

Review 8.  Chancroid: from clinical practice to basic science.

Authors:  D A Lewis
Journal:  AIDS Patient Care STDS       Date:  2000-01       Impact factor: 5.078

9.  Epidemiologic, clinical, laboratory, and therapeutic features of an urban outbreak of chancroid in North America.

Authors:  G W Hammond; M Slutchuk; J Scatliff; E Sherman; J C Wilt; A R Ronald
Journal:  Rev Infect Dis       Date:  1980 Nov-Dec

10.  Specificity of the immune response to Haemophilus ducreyi.

Authors:  T J Brown; R C Ballard; C A Ison
Journal:  Microb Pathog       Date:  1995-07       Impact factor: 3.738

View more
  8 in total

1.  Expression of Haemophilus ducreyi collagen binding outer membrane protein NcaA is required for virulence in swine and human challenge models of chancroid.

Authors:  Robert A Fulcher; Leah E Cole; Diane M Janowicz; Kristen L Toffer; Kate R Fortney; Barry P Katz; Paul E Orndorff; Stanley M Spinola; Thomas H Kawula
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

2.  Putative vaccine candidates and drug targets identified by reverse vaccinology and subtractive genomics approaches to control Haemophilus ducreyi, the causative agent of chancroid.

Authors:  Alissa de Sarom; Arun Kumar Jaiswal; Sandeep Tiwari; Letícia de Castro Oliveira; Debmalya Barh; Vasco Azevedo; Carlo Jose Oliveira; Siomar de Castro Soares
Journal:  J R Soc Interface       Date:  2018-05       Impact factor: 4.118

3.  The Haemophilus ducreyi trimeric autotransporter adhesin DsrA protects against an experimental infection in the swine model of chancroid.

Authors:  William G Fusco; Neelima R Choudhary; Patty A Routh; Melissa S Ventevogel; Valerie A Smith; Gary G Koch; Glen W Almond; Paul E Orndorff; Gregory D Sempowski; Isabelle Leduc
Journal:  Vaccine       Date:  2014-05-18       Impact factor: 3.641

4.  Immunization with the Haemophilus ducreyi hemoglobin receptor HgbA with adjuvant monophosphoryl lipid A protects swine from a homologous but not a heterologous challenge.

Authors:  William G Fusco; Galyna Afonina; Igor Nepluev; Deborah M Cholon; Neelima Choudhary; Patricia A Routh; Glenn W Almond; Paul E Orndorff; Herman Staats; Marcia M Hobbs; Isabelle Leduc; Christopher Elkins
Journal:  Infect Immun       Date:  2010-06-28       Impact factor: 3.441

5.  Experimental infection of human volunteers with Haemophilus ducreyi: fifteen years of clinical data and experience.

Authors:  Diane M Janowicz; Susan Ofner; Barry P Katz; Stanley M Spinola
Journal:  J Infect Dis       Date:  2009-06-01       Impact factor: 5.226

6.  Immunization with the Haemophilus ducreyi hemoglobin receptor HgbA protects against infection in the swine model of chancroid.

Authors:  Galyna Afonina; Isabelle Leduc; Igor Nepluev; Chrystina Jeter; Patty Routh; Glen Almond; Paul E Orndorff; Marcia Hobbs; Christopher Elkins
Journal:  Infect Immun       Date:  2006-04       Impact factor: 3.441

Review 7.  Pirates of the haemoglobin.

Authors:  Daniel Akinbosede; Robert Chizea; Stephen A Hare
Journal:  Microb Cell       Date:  2022-02-18

8.  Outer membrane protein P4 is not required for virulence in the human challenge model of Haemophilus ducreyi infection.

Authors:  Diane M Janowicz; Beth W Zwickl; Kate R Fortney; Barry P Katz; Margaret E Bauer
Journal:  BMC Microbiol       Date:  2014-06-24       Impact factor: 3.605

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.